Bieżący numer
Archiwum
Artykuły zaakceptowane
O czasopiśmie
Rada naukowa
Bazy indeksacyjne
Kontakt
Zasady publikacji prac
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
1/2020
vol. 95 streszczenie artykułu:
Artykuł oryginalny
Selective IgA deficiency – does partial mean negligible?
Katarzyna Tąpolska-Jóźwiak
1
,
Aleksandra Szczawińska-Popłonyk
1
Pediatr Pol 2020; 95 (1): 1–5
Data publikacji online: 2020/03/31
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction Selective immunoglobulin A deficiency (SIgAD) is the most common primary immunodeficiency in the Caucasian population. The current definition describes SIgAD as serum IgA level below 0.07 g/l in individuals of four years of age or older with normal immunoglobulin G and M levels, in whom other causes of hypogammaglobulinaemia have been excluded. Most patients with SIgAD are asymptomatic, but some of them suffer from recurrent infections, primarily involving the respiratory system, allergies, autoimmune disorders, and malignancies. In contrast to “absolute” SIgAD, the clinical relevance of partial SIgAD has not yet been determined. Aim of the study To compare the clinical course of absolute and partial SIgAD in children. Material and methods The study was conducted through a retrospective review of the medical records of 25 children with absolute and 33 children with partial SIgAD, aged between 4 and 18 years, for the occurrence of recurrent respiratory, urinary, and gastrointestinal tract infections, as well as allergy, autoimmunity, and malignancies. Results Respiratory tract infections were the most common clinical manifestation in both variants of SIgAD and affected nearly two-thirds of patients with absolute and about three-quarters with partial SIgAD. Apart from autoimmunity in total, which occurred more often in children with absolute than partial SIgAD (44% vs. 12.12%, p = 0.006), no statistically significant differences were found between the incidence of the analysed conditions in both groups. Conclusions Due to the similar clinical course of both variants of SIgAD, all symptomatic patients should receive specialist care and undergo systematic follow-up visits. In children with autoimmune diseases basic immunology screening should be considered. |